KS
NANDADEEPA CANCER CLINIC, HCG gulbarga, Sri Shankara Cancer Hospital and Research Center, MS Ramaiah Medical College, Kerudi cancer centre
0000-0003-2110-1233
About
Dr Sandeep K S
clinical interest: medical oncology
Education qualification : MBBS, MD( radiation oncology) DNB (medical oncology) ECMO( european society of medical oncology certification), CCEPC ( palliative care)
Expertise: Dr. K S pursued further specialization, obtaining an MD from MS Ramaiah medical college, followed by a Diplomate of National Board (DNB) in Medical Oncology. He also holds the European Society of Medical Oncology (ESMO) certification, for his knowledge in medical oncology. He holds a Certificate Course in Essentials of Palliative Care (CCEPC), reflecting his holistic approach to patient care and his understanding of the importance of addressing the diverse needs of cancer patients. He is particularly passionate about incorporating cutting-edge therapies and personalized treatment approaches to optimize patient outcomes and quality of life. In addition to his clinical practice, Dr. K S is actively involved in research and academics he has various publication and presentations in national and international journals.
PUBLICATIONS:
Original articles-
1) Clinicopathological Profile, Treatment Response and Survival of Cervical Cancer Patients from a Tertiary Cancer Centre in North Karnataka- May 2022-Asian Pacific Journal of Cancer Care 7(2):213-217
2) Molecular marker as a prognostic indicator in head and neck cancer patients-IASO Nov 2018
3) Tolerance of radical radiation in elderly head and neck cancer patients-IJSO Nov 2019
4) Exceptional responders to immunotherapy: a rare case of post-HSCT relapse responding to Nivolumab – IJHOSCR April 2019
5) Intraconal metastasis leading to diagnosis of hepatocellular carcinoma – middle east journal of dig disease, Jan 2020
6) Clinical outcomes and safety study of cdk4/6 inhibitors in hormone-positive metastatic breast cancer -a real world tertiary cancer centre experience- 2024 ijc
7) Clinical benefit and safety of palbociclib in hormone positive breast cancer with visceral metastasis- real world experience from a tertiary cancer centre- 2024 IJMPO
Awards:
1. Best oral presentation – Amrit lal Parikh Award (Indian Cancer Congress 2023 Mumbai)
Employment
-
NANDADEEPA CANCER CLINIC consultant medical oncologist2024 - Present
-
HCG gulbarga consultant medical oncologist2024 - 2024
-
Kerudi cancer centre Consultant2018 - 2020
Education
-
Sri Shankara Cancer Hospital and Research Center seniour resident2020 - 2023
-
MS Ramaiah Medical College MD2015 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (8)
- Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience Save
- Clinical Benefit and Safety of Palbociclib in Hormone Positive Breast Cancer with Visceral Metastasis: Real-World Experience from a Tertiary Cancer Center Save
- Clinicopathological Profile, Treatment Response and Survival of Cervical Cancer Patients from a Tertiary Cancer Centre in North Karnataka Save
- Isolated trigeminal neuralgia: An early weird presentation of carcinoma breast Save
- Tolerance of Radical Radiotherapy Among Elderly Head and Neck Cancer Patients Save
- Intraconal Metastasis Leading to Diagnosis of Hepatocellular Carcinoma Save
- Exceptional Responder to Immunotherapy: A Rare Case of Post-HSCT DLBCL Relapse Responding to Nivolumab. Save
- Molecular Marker as a Prognostic Indicator in Head and Neck Cancer Patients Save